Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 2Withdrawn 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 5Colorectal Neoplasms 4Squamous Cell Carcinoma of Head and Neck 2Prostatic Neoplasms 2Pancreatic Neoplasms 2Colonic Neoplasms 2Tongue Neoplasms 1Melanoma 1Localized Resectable Adult Primary Liver Cancer 1Liver Neoplasms 1Head and Neck Neoplasms 1Gallbladder Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Intraductal, Noninfiltrating 1Carcinoma, Hepatocellular 1Bile Duct Neoplasms 1Adenocarcinoma, Bronchiolo-Alveolar 1Adenocarcinoma of Lung 1

Interventions

ricolinostat 1galactomannan 1Platinum 1Phototherapy 1Photochemotherapy 1Pharmacogenomic Testing 1MK 2206 1Laser Therapy 1Gemcitabine 1Fluorouracil 1Electroporation 1Dihematoporphyrin Ether 1Cisplatin 1Chemotherapy, Adjuvant 1AZD 6244 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Bile Duct Neoplasms × Chemotherapy, Adjuvant × Clear all
NCT00253617 2013-04-04

Stent Placement With or Without Photodynamic Therapy Using Porfimer Sodium as Palliative Treatment in Treating Patients With Stage III or Stage IV Cholangiocarcinoma That Cannot Be Removed By Surgery

National Cancer Institute (NCI)

Phase 3 Withdrawn
Gastrointestinal

Bile Duct Neoplasms, Gallbladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡